Suppr超能文献

慢性淋巴细胞白血病中骨髓组织学的预后价值。对来自单一机构的335例未经治疗病例的研究。

Prognostic value of bone marrow histology in chronic lymphocytic leukemia. A study of 335 untreated cases from a single institution.

作者信息

Mauro F R, De Rossi G, Burgio V L, Caruso R, Giannarelli D, Monarca B, Romani C, Baroni C D, Mandelli F

机构信息

University La Sapienza of Rome, Human Biopathology Dept., Italy.

出版信息

Haematologica. 1994 Jul-Aug;79(4):334-41.

PMID:7806088
Abstract

BACKGROUND AND METHODS

A significant correlation between bone marrow (BM) histology, survival and disease progression (DP) probability has been observed by several authors in chronic lymphocytic leukemia (CLL). The prognostic value of BM histologic patterns on survival and disease progression probability was investigated in 335 B-CLL patients.

RESULTS

Actuarial survival probability estimated by univariate analysis proved to be significantly influenced by stage (p < 0.0001), BM histology (p = 0.01), and by the following parameters: anemia (p = 0.0005), splenomegaly (p < 0.001), CLL-related symptoms (p < 0.01), thrombocytopenia (p < 0.01), number of involved nodal areas (p = 0.01) and peripheral lymphocyte count over 30 x 10(9)/L (p < 0.05). In this series we did not detect a discriminating prognostic effect for BM histology within the individual stages. Cox multivariate regression analysis failed to demonstrate a significant value for BM histology, while stage and anemia emerged as the best prognostic variables. Actuarial DP free probability in 294 untreated patients with A and B stages was significantly related to stage (p < 0.00001) and to BM pattern (p = 0.01).

CONCLUSIONS

Despite the clear correlation between the D pattern of BM involvement and advanced and early progressive disease, we were unable to demonstrate an independent prognostic value for BM histology. These findings suggest that stage emerged as the best predictive factor of survival probability in our B-CLL patients.

摘要

背景与方法

几位作者在慢性淋巴细胞白血病(CLL)中观察到骨髓(BM)组织学、生存率与疾病进展(DP)概率之间存在显著相关性。在335例B-CLL患者中研究了BM组织学模式对生存率和疾病进展概率的预后价值。

结果

单因素分析估计的精算生存概率受分期(p < 0.0001)、BM组织学(p = 0.01)以及以下参数的显著影响:贫血(p = 0.0005)、脾肿大(p < 0.001)、CLL相关症状(p < 0.01)、血小板减少(p < 0.01)、受累淋巴结区域数量(p = 0.01)和外周淋巴细胞计数超过30×10⁹/L(p < 0.05)。在本系列研究中,我们未在各个分期内检测到BM组织学具有鉴别预后的作用。Cox多因素回归分析未能证明BM组织学具有显著价值,而分期和贫血是最佳的预后变量。294例未经治疗的A期和B期患者的无疾病进展精算概率与分期(p < 0.00001)和BM模式(p = 0.01)显著相关。

结论

尽管BM受累的D模式与晚期和早期进展性疾病之间存在明显相关性,但我们无法证明BM组织学具有独立的预后价值。这些发现表明,分期是我们的B-CLL患者生存概率的最佳预测因素。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验